Psychische Veränderungen bei Hypo- und Hyperthyreosen

Psychiatrische Auffälligkeiten bei Patienten mit Schilddrüsenfunktionsstörungen können sehr vielgestaltig sein. So werden häufig kognitive Funktionsstörungen und depressive Zustandsbilder, seltener Angststörungen sowie psychotische Zustände mit Wahnvorstellungen und Halluzinationen beschrieben. Wie aus Fallsammlungen bekannt kann sich eine Hypo- bzw. Hyperthyreose alleine durch diese psychischen Veränderungen manifestieren, ohne dass typisch organisch geprägte Symptome bestehen müssen. Um eine zugrundeliegende Schilddrüsenerkrankung frühzeitig erkennen und gezielt behandeln zu können, ist die Kenntnis psychischer Manifestationsformen erforderlich.

Diese Übersicht soll die psychiatrischen Manifestationen bei Patienten mit Schilddrüsenfunktionsstörungen erläutern und deren diagnostische Abgrenzung zu primär psychiatrischen Erkrankungen aufzeigen.

Literatur

• 1 Aronson R, Offman H J, Joffe R T, Naylor C D. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.  Arch Gen Psychiatry. 1996;  53 842-848
• 2 Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients: a systematic review.  Arch Intern Med. 1999;  159 658-665
• 3 Baldini I M, Vita A, Mauri M C. et al . Psychopathological and cognitive features in subclinical hypothyroidism.  Prog Neuropsychopharmacol Biol Psychiatry. 1997;  21 925-935
• 4 Bauer M, Hellweg R, Graf K J, Baumgartner A. Treatment of refractory depression with high-dose thyroxine.  Neuropsychopharmacology. 1998;  18 444-55
• 5 Brownlie B E, Rae A M, Walshe J W, Wells J E. Psychoses associated with thyrotoxicosis - »thyrotoxic psychosis«: A report of 18 cases, with statistical analysis of incidence.  Eur J Endocrinol. 2000;  142 4384-44
• 6 Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange A J Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.  N Engl J Med. 1999;  340 424-429
• 7 Calabrese J R, Gulledge A D, Hahn K. et al . Autoimmune thyroiditis in manic-depressive patients treated with lithium.  Am J Psychiatry. 1985;  142 1318-1321
• 8 Caudill T G, Lardinois C K. Severe thyrotoxicosis presenting as acute psychosis.  West J Med. 1991;  155 292-293
• 9 Cho J T, Bone S, Dunner D L, Colt E, Fieve R R. The effect of lithium treatment on thyroid function in patients with primary affective disorder.  Am J Psychiatry. 1979;  136 115-116
• 10 Chopra I J, Solomon D H, Huang T S. Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay.  Metabolism. 1990;  39 538-543
• 11 Cooper D S, Halpern R, Wood L C, Levin A A, Ridgway E C. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial.  Ann Intern Med. 1984;  101 18-24
• 12 Cowdry R W, Wehr T A, Zis A P, Goodwin F K. Thyroid abnormalities associated with rapid-cycling bipolar illness.  Arch Gen Psychiatry. 1983;  40 414-420
• 13 De Groot L J. Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome.  J Clin Endocrinol Metab. 1999;  84 151-64
• 14 Eagles J M, McCann I, MacLeod T N, Paterson N. Lithium monitoring before and after the distribution of clinical practice guidelines.  Acta Psychiatr Scand. 2000;  101 349-353
• 15 Enns M, Ross C, Clark P. Thyroid screening tests in psychiatric inpatients.  Gen Hosp Psychiatry. 1992;  14 334-339
• 16 Escobar-Morreale H F, del Rey F E, Obregon M J, de Escobar G M. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.  Endocrinology. 1996;  137 2490-2502
• 17 Geffken G R, Ward H E, Staab J P, Carmichael S L, Evans D L. Psychiatric morbidity in endocrine disorders.  Psychiatr Clin North Am. 1998;  21 473-489
• 18 Granet R B, Kalman T P. Hypothyroidism and psychosis: a case illustration of the diagnostic dilemma in psychiatry.  J Clin Psychiatry. 1978;  39 260-263
• 19 Gunnarsson T, Sjoberg S, Eriksson M, Nordin C. Depressive symptoms in hypothyroid disorder with some observations on biochemical correlates.  Neuropsychobiology. 2001;  43 70-74
• 20 Haggerty J J, Stern R A, Mason G A, Beckwith J, Morey C E, Prange A J. Subclinical hypothyroidism: a modifiable risk factor for depression?.  American Journal of Psychiatry. 1993;  150 508-510
• 21 Hall R C. Psychiatric effects of thyroid hormone disturbance.  Psychosomatics. 1983;  24 7-11, 15 - 18
• 22 Howland R H. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment.  J Clin Psychiatry. 1993;  54 47-54
• 23 Hutto B. Subtle psychiatric presentations of endocrine diseases.  Psychiatr Clin North Am. 1998;  21 905-916, viii
• 24 Jaeschke R, Guyatt G, Gerstein H. et al . Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?.  J Gen Intern Med. 1996;  11 744-749
• 25 Jefferson J W. Lithium: the present and the future.  J Clin Psychiatry. 1990;  51 (Suppl) 4-8; discussion 17 - 9
• 26 Johnston A M, Eagles J M. Lithium-associated clinical hypothyroidism. Prevalence and risk factors.  Br J Psychiatry. 1999;  175 336-339
• 27 Kirov G. Thyroid disorders in lithium-treated patients.  J Affect Disord. 1998;  50 33-40
• 28 Lederbogen F, Hermann D, Hewer W, Henn F A. Thyroid function test abnormalities in newly admitted psychiatric patients residing in an iodine-deficient area: patterns and clinical significance.  Acta Psychiatr Scand. 2001;  104 305-310
• 29 Leigh H, Kramer S I. The psychiatric manifestations of endocrine disease.  Adv Intern Med. 1984;  29 413-45
• 30 Lerch M, Meier C, Staub J J. Is there a need for treatment in subclinical hypo- and hyperthyroidism?.  Ther Umsch. 1999;  56 369-373
• 31 Leutgeb U. Ambient iodine and lithium-associated with clinical hypothyroidism.  Br J Psychiatry. 2000;  176 495-496
• 32 Logotheis J. Psychotic behavior as the initial indicator of adult myxedema.  J Nerv Ment Dis. 1963;  136 561-568
• 33 Loosen P T, Prange A J. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review.  Am J Psychiatry. 1982;  139 405-416
• 34 Magliozzi J R, Maddock R J, Gold A S, Gietzen D W. Relationships between thyroid indices and symptoms of anxiety in depressed outpatients.  Ann Clin Psychiatry. 1993;  5 111-116
• 35 Meier C, Staub J J, Roth C B. et al . Tsh-controlled l-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).  J Clin Endocrinol Metab. 2001;  86 4860-4866
• 36 Monzani F, Del Guerra P, Caraccio N. et al . Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment.  Clinical Investigator. 1993;  71 367-371
• 37 Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with »subclinical« hypothyroidism.  Clin Endocrinol (Oxf). 1988;  29 63-75
• 38 Placidi G P, Boldrini M, Patronelli A. et al . Prevalence of psychiatric disorders in thyroid diseased patients.  Neuropsychobiology. 1998;  38 222-225
• 39 Smith C K, Barish J, Correa J, Williams R H. Psychiatric disturbance in endocrinologic disease.  Psychosom Med. 1972;  34 69-86
• 40 Taylor J W. Depression in thyrotoxicosis.  Am J Psychiatry. 1975;  132 552-553
• 41 Whybrow P C, Bauer M. Behavioral and psychiatric aspects of hypothyroidism. 8 ed. New York: Lippincott Williams and Wilkins In: Braverman LE, Utiger RU, eds. Werner and Ingbar’s The Thyroid 2000: 837
• 42 Whybrow P C, Bauer M. Behavioral aspects of thyrotoxicosis. 8 ed. New York: Lippincott Williams and Wilkins In: Braverman LE, Utiger RU, eds. Werner and Ingbar’s The Thyroid 2000: 673
• 43 Woolf P D, Nichols D, Porsteinsson A, Boulay R. Thyroid evaluation of hospitalized psychiatric patients: the role of TSH screening for thyroid dysfunction.  Thyroid. 1996;  6 451-456